Alan Fuhrman - Insider Trading & Ownership

Entity
Individual
Location
C/O Ambit Biosciences Corporation, 11080 Roselle Street, San Diego, CA
Summary
The estimated net worth of Alan Fuhrman is at least $1.04M dollars as of November 1, 2024. Alan Fuhrman is the Director of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $698K. Alan Fuhrman is the Chief Financial Officer of Tyra Biosciences, Inc. and owns shares of Tyra Biosciences, Inc. (TYRA) stock worth about $206K. Alan Fuhrman is the Director of Esperion Therapeutics, Inc. and owns shares of Esperion Therapeutics, Inc. (ESPR) stock worth about $133K.
All Insider Reports
All Insider Reports

Ownership of Alan Fuhrman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SWTX SpringWorks Therapeutics, Inc. Director $698K May 16, 2024
TYRA Tyra Biosciences, Inc. Chief Financial Officer $206K +$152K +284% Oct 30, 2024
ESPR Esperion Therapeutics, Inc. Director $133K May 23, 2024
CMPI Checkmate Pharmaceuticals, Inc. Director May 31, 2022

Insider Transactions Reported by Alan Fuhrman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.